Efficacy of lapatinib monotherapy on occult breast cancer
4.7 (136) · $ 24.00 · In stock
Frontiers Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breast
Oncol Lett:抗HER2单药治疗隐匿性乳腺癌1例- 数字病理远程诊断与质控平台
PDF) Recurrent Her-2 positive occult breast cancer presenting with zosteriform cutaneous metastases: a case report
Breast cancer Nature Reviews Disease Primers
PDF) Retrospective Analysis of Capecitabine Monotherapy in Patients with Metastatic Breast Cancer: A Single Center Experience
PRIMARY THERAPY OF EARLY BREAST CANCER 12th - Oncoletter
20745 PDFs Review articles in ERYTHEMA
Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Disease Study Group of Japan and the Japanese Study Group of the Standard Antiviral
Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis - ScienceDirect
Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases. - Abstract - Europe PMC
20745 PDFs Review articles in ERYTHEMA
Trastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report
Full article: Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?